One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1016/j.annonc.2023.10.038
Copy DOI Journal: Annals of Oncology |  Publication Date: Oct 1, 2023 |
Affiliation: Fudan University Shanghai Cancer Center, Shandong Tumor Hospital, Shandong First Medical University, University of Electronic Science and Technology of China, Sichuan Cancer Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Huazhong University of Science and Technology, Union Hospital, Tianjin Central Hospital of Gynecology Obstetrics, Jiangsu Hengrui Medicine (China), Central South University, Hunan Cancer Hospital, Henan Cancer Hospital, Zhengzhou University, Zhejiang Cancer Hospital, Guangxi Medical University, Tianjin Medical University Cancer Institute and Hospital, Chongqing Cancer Hospital, Chongqing University, Liaoning Cancer Hospital & Institute, Shanxi Provincial Cancer Hospital, Kunming Medical UniversityLBA44 Camrelizumab plus famitinib versus camrelizumab alone and investigator’s choice of chemotherapy in women with recurrent or metastatic cervical cancer
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
